TI
NVCR icon

Tidal Investments’s NovoCure NVCR Stock Holding History

Tidal Investments’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
77,252
+19,873
+35% +$301K ﹤0.01% 1665
2026
Q1 		$625K Buy
57,379
+5,958
+12% +$74.4K ﹤0.01% 1724
2025
Q4 		$665K Buy
51,421
+2,857
+6% +$36.7K ﹤0.01% 1488
2025
Q3 		$627K Sell
48,564
-1,845
-4% -$24.7K ﹤0.01% 1443
2025
Q2 		$897K Buy
50,409
+5,647
+13% +$98.4K 0.01% 1088
2025
Q1 		$798K Sell
44,762
-1,398
-3% -$31.8K 0.01% 1070
2024
Q4 		$1.38M Sell
46,160
-9,596
-17% -$203K 0.01% 861
2024
Q3 		$871K Buy
55,756
+2,465
+5% +$44.7K 0.01% 1067
2024
Q2 		$913K Buy
53,291
+8,825
+20% +$155K 0.01% 947
2024
Q1 		$695K Buy
+44,466
New +$654K 0.01% 1052

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Tidal Investments's NVCR Position: Q2 2026 in Review

Tidal Investments increased its NovoCure (NVCR) stake by 35% in Q2 2026, buying an estimated $301K and bringing the position to 77,252 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Tidal Investments first reported a position in NVCR in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.38M in Q4 2024. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Tidal Investments held 77,252 shares of NovoCure worth $1.17M as of Q2 2026.
  • Tidal Investments bought 19,873 NovoCure shares in Q2 2026, an estimated $301K.
  • NovoCure made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1665 holding.
  • Tidal Investments first reported a position in NovoCure in Q1 2024 and has held it in 10 quarters since.
  • Tidal Investments's NovoCure position peaked at $1.38M in Q4 2024.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.